Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura

Page, Evaren E; Kremer Hovinga, Johanna Anna; Terrell, Deirdra R; Vesely, Sara K; George, James N (2016). Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood, 127(24), pp. 3092-3094. American Society of Hematology 10.1182/blood-2016-03-703827

[img]
Preview
Text
JKH_blood-2016-03-703827_Rituximab reduces Risk...full.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (176kB) | Preview
[img] Text
3092.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (576kB) | Request a copy

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Hämatologie (Erwachsene)

UniBE Contributor:

Kremer Hovinga, Johanna Anna

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0006-4971

Publisher:

American Society of Hematology

Language:

English

Submitter:

Verena Zwahlen

Date Deposited:

12 Jul 2016 11:48

Last Modified:

22 Sep 2017 16:32

Publisher DOI:

10.1182/blood-2016-03-703827

PubMed ID:

27060171

BORIS DOI:

10.7892/boris.82404

URI:

https://boris.unibe.ch/id/eprint/82404

Actions (login required)

Edit item Edit item
Provide Feedback